JPRN-UMIN000002134未知1 期
Immunotherapy with NK cells - Immunotherapy with NK cells
Kuramae clinic0 个研究点目标入组 15 人开始时间: 2009年7月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5years-old 至 120years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Uncontrollable infection 2.Serious cardiac disease 3.Active autoimmune disease 4.Pulmonary fibrosis or interstitial pneumonia, or their history, or predisposition to them 5.Serious drug allergy
研究者
相似试验
招募中
不适用
Development of novel immunotherapy using NKT cells for malignant solid tumors in childreHealthy volunteersJPRN-UMIN000048076Chiba University30
尚未招募
2 期
Abatacept Mediated Natural Killer Cell-Based ImmunotherapyCTRI/2021/09/036713Manashi Chakrabarti Foundation
已完成
不适用
atural Killer (NK) Cell Therapy Combined with Hepatic Artery Infusion Chemotherapy (HAIC) in Patients with Advanced Hepatocellular CarcinomaNeoplasmsKCT0004642Vaxcell-Bio20
已完成
2 期
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)NSCLC Stage IIIA/BNCT02118415Technical University of Munich13
进行中（未招募）
1 期
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with Non-Small Cell Lung Cancer (NSCLC) after radiochemotherapy (RCT)EUCTR2008-002130-30-DETechnische Universität München Fakultät für Medizin90